Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowCancer Gene Therapy is a journal focused on gene and cellular therapy for cancer researchers and clinicians.
Looking to publish in Cancer Gene Therapy? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Cancer Gene Therapy accepts the following article types. Click on an article type to view submission instructions.
Article
Review Article
Brief Communication
Correspondence
Perspective
Recent Publications
A p53 peptide mucosal vaccine induces cellular and humoral immunity and anti-tumor effects in a murine colorectal cancer model
Su He Wang, Zhengyi Cao, Katarzyna W. Janczak, Ying Feng, Maranne Green, Shengzhuang Tang, Eric R. Fearon, James R. Baker
Amitriptyline inhibits EAG1 channels by binding to their PAS domains and exerts EAG1-dependent anti-tumorigenic effects
Joos Berghausen, Clementine A. D. Thomas, Ze-Jun Wang, Kyle Kihn, Eric Glasgow, Tinatin I. Brelidze
SPARC family proteins: matricellular modulators of cancer progression and therapeutic resistance
Rachel Huey Xuan Hoe, Thamil Selvee Ramasamy, Ajantha Sinniah, Ain Zubaidah Ayob
WTAP stabilized by USP7 contributes to enzalutamide resistance in prostate cancer via mediating AKT m6A-modification
Ruxue Shi, Kai Gu, Haichuan Li, Qingwei Sun, Xinyu Wu, Shuhong Huang, Qingxia Hu
Correction to: Methylation of SFRP5 is related to multidrug resistance in leukemia cells
H. Wang, X. Wang, R. Hu, W. Yang, A. Liao, C. Zhao, J. Zhang, Z. Liu
Frequently asked questions
How long does it take to publish?
Submission to first editorial decision: 5 median days. Submission to acceptance: 138 median days.
Reformat to Cancer Gene Therapy using Livewrite PremiumIs a cover letter required?
A cover letter on institutional letterhead is required at first submission.
Reformat to Cancer Gene Therapy using Livewrite PremiumWhat are the publication costs?
Standard publication is behind a paywall. Gold open access is available with an APC of £2,990 / $4,290 / €3,490, plus VAT or local taxes where applicable.
Reformat to Cancer Gene Therapy using Livewrite Premium